Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Prolyse in acute cerebral thromboembolism

Middle Cerebral Artery Occlusion and the PROACT Trial The safety and efficacy of lAT in the anterior circulation have been evaluated in two randomized, multicenter, placebo-controlled trials. In the Prolyse in Acute Cerebral Thromboembolism (PROACT) 1 and 11 trials, patients with proximal MCA (Ml or M2 segment) occlusions within 6 hours of symptom onset were treated with recombinant prourokinase (r-pro-UK) or placebo. ... [Pg.66]

Furlan A, Higashida R, Wechsler L, Gent M, Rowley H, Kase C, Pessin M, Ahuja A, Callahan F, Clark WM, Silver F, Rivera F. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA 1999 282 2003-2011. [Pg.92]

Intra-arterial thrombolytics may improve outcomes in selected patients with acute ischemic stroke due to large-vessel occlusion. Patients in the Prolyse in Acute Cerebral Thromboembolism II (PROACT II) trial were given 9 mg prourokinase (r-pro UK)... [Pg.168]

Del Zoppo GJ, Higashida RT, Furlan AJ, Pessin MS, Rowley HA, Gent M (1998) PROACT a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. PROACT Investigators. Prolyse in acute cerebral thromboembolism. Stroke 29 4-11. [Pg.79]

See other pages where Prolyse in acute cerebral thromboembolism is mentioned: [Pg.92]    [Pg.173]    [Pg.262]    [Pg.265]    [Pg.241]    [Pg.280]    [Pg.288]    [Pg.92]    [Pg.173]    [Pg.262]    [Pg.265]    [Pg.241]    [Pg.280]    [Pg.288]   
See also in sourсe #XX -- [ Pg.280 ]



SEARCH



Cerebral

Cerebritis

Thromboembolism

© 2024 chempedia.info